CAPTRUST Financial Advisors’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
15,941
+9,796
+159% +$637K ﹤0.01% 1433
2026
Q1
$292K Buy
+6,145
New +$276K ﹤0.01% 2407
2022
Q3
Sell
-759
Closed -$27K 3920
2022
Q2
$27K Buy
759
+382
+101% +$13.5K ﹤0.01% 3203
2022
Q1
$19K Buy
377
+76
+25% +$4.21K ﹤0.01% 3428
2021
Q4
$23K Sell
301
-78
-21% -$8.01K ﹤0.01% 3210
2021
Q3
$41K Sell
379
-460
-55% -$52.7K ﹤0.01% 2713
2021
Q2
$112K Buy
839
+238
+40% +$27.7K ﹤0.01% 1949
2021
Q1
$74K Buy
601
+281
+88% +$42.7K ﹤0.01% 2162
2020
Q4
$45K Buy
320
+140
+78% +$15.5K ﹤0.01% 1879
2020
Q3
$14K Buy
+180
New +$11.2K ﹤0.01% 2148

Other funds holding TWST

CAPTRUST Financial Advisors's TWST Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Twist Bioscience (TWST) stake by 159% in Q2 2026, buying an estimated $637K and bringing the position to 15,941 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

CAPTRUST Financial Advisors first reported a position in TWST in Q3 2020 and has held it in 10 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • CAPTRUST Financial Advisors held 15,941 shares of Twist Bioscience worth $1.64M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 9,796 Twist Bioscience shares in Q2 2026, an estimated $637K.
  • Twist Bioscience made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1433 holding.
  • CAPTRUST Financial Advisors first reported a position in Twist Bioscience in Q3 2020 and has held it in 10 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.